Select Medical Holdings Corp. closed a $3.9 billion take-private transaction this week, removing one of the largest post-acute care operators from public markets. The deal transferred ownership of over 100 NovaCare Rehabilitation clinics and the broader Select Medical hospital network to a private equity consortium whose composition has not been disclosed in available filings.

The transaction marks the second major PE entry into scaled physical therapy platforms in eighteen months. Select Medical operated as a public company since 2009, reporting $6.2 billion in trailing revenue across inpatient rehabilitation hospitals, long-term acute care facilities, and outpatient physical therapy. The $3.9 billion enterprise value implies a multiple in the mid-single digits on EBITDA, consistent with recent post-acute care comps but below the 7-9x range commanded by pure-play outpatient PT rollups.

The timing reflects three converging pressures. First, Medicare reimbursement rates for post-acute services remain under administrative scrutiny, with CMS proposing a 1.4% rate reduction for inpatient rehabilitation facilities in the 2025 proposed rule. Second, labor costs in skilled nursing and therapy settings have risen 12-18% since 2021, compressing margins for operators without pricing power. Third, private equity has accumulated $48 billion in committed healthcare services capital through Q4 2024, seeking assets with defensible payor mix and footprint density.

What separates this deal from prior PT rollup activity is the inclusion of Select's critical illness recovery hospitals, which serve as Medicare Advantage discharge destinations. MAO penetration in the 65+ cohort now exceeds 54% nationally, and plans are steering post-discharge care toward vertically integrated or preferred networks. A private owner can restructure Select's hospital-to-outpatient care pathways without quarterly earnings calls, potentially bundling services for MAO contracts in ways public shareholders would not tolerate in the near term.

Operators and allocators should track three follow-on signals. First, whether the acquirer begins divesting non-core assets within 90-120 days, a common PE playbook move to recoup acquisition financing costs. Second, any announced partnerships with large MAO plans, particularly Humana or UnitedHealth's Optum, which would validate the thesis that bundled post-acute care can command premium rates. Third, competitor responses—Encompass Health and Brookdale Senior Living both face similar margin compression and may draw acquisition interest if Select's new structure proves out.

The deal removes $6.2 billion in revenue from public healthcare services comps, leaving a thinner peer set for valuation work. More relevant: it confirms that private capital now views physical therapy and post-acute care as a single value chain, not separate verticals, and is willing to pay for density even at compressed multiples.